B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tg Therapeuticscmn (NQ: TGTX )

17.36 -0.61 (-3.39%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,344,394
Open 17.47
Bid (Size) 17.30 (20)
Ask (Size) 17.40 (4)
Prev. Close 17.97
Today's Range 17.11 - 18.31
52wk Range 3.480 - 18.31
Shares Outstanding 145,341,967
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Latest Analyst Ratings for TG Therapeutics
 
Via Benzinga
Here's How Much $1000 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today
 
Via Benzinga

Performance

YTD
+50.04%
+50.04%
1 Month
+69.70%
+69.70%
3 Month
+206.71%
+206.71%
6 Month
+130.85%
+130.85%
1 Year
+71.03%
+71.03%

More News

Read More
'A Class Action Lawsuit Against TG Therapeutics Has Been Dismissed'
Via Benzinga
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
Via Benzinga
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
Via Benzinga
Why TG Therapeutics Stock Was a Solid Winner This Week
Via The Motley Fool
Analyst Ratings for TG Therapeutics
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know
Via Benzinga
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
Via Benzinga
Shaw Communications, Enovix And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
Via Benzinga
B of A Securities Maintains Underperform Rating for TG Therapeutics: Here's What You Need To Know
Via Benzinga
What's Going On With TG Therapeutics Shares
Via Benzinga
TG Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
Why Shares of TG Therapeutics Climbed 59.9% This Week
Via The Motley Fool
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Tesla To $250? Here Are 10 Other Price Target Changes For Thursday
Via Benzinga
Tesla, Hyzon Motors And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Via Benzinga
Pfizer Makes Progress, but This Biotech Was Wednesday's Big Winner
Via The Motley Fool
Here's Why TG Therapeutics (TGTX) Shares Are Skyrocketing
Via Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Via Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.